Mapping evidence on the risk factors associated with pediatric cancers in sub-Saharan Africa: a scoping review

Sehlisiwe Ndlovu1, Mbuzeleni Hlongwa2,3, Themba Ginindza2

  • 1Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa. sehlisiwen@gmail.com.

Systematic Reviews
|April 5, 2022
PubMed

Insights

Evidence on pediatric cancer risk factors in sub-Saharan Africa is limited, with infection-induced cancers like Burkitt Lymphoma being most common. More research is needed to control childhood cancers effectively.

Area of Science:

  • Pediatric Oncology
  • Epidemiology
  • Public Health in Africa

Background:

  • Pediatric cancers are rare and heterogeneous, complicating risk factor assessment.
  • Limited evidence exists for etiological factors in childhood cancers, particularly in low- and middle-income countries (LMICs).
  • Sub-Saharan Africa (SSA) faces a growing burden of non-communicable diseases, including pediatric cancers, necessitating focus on associated risk factors.

Purpose of the Study:

  • To systematically map existing evidence on risk factors for pediatric cancers in sub-Saharan Africa (SSA).

Main Methods:

  • A scoping review guided by Arksey and O'Malley's framework.
  • Searched four electronic databases (PubMed, Health Source: Nursing/Academic Edition, Google Scholar) in December 2018 and February 2022.
  • Included studies on children aged 0-15 years, adhering to PRISMA-ScR guidelines.

Main Results:

  • Fifteen studies were included from 7391 retrieved articles.
  • Infection-induced factors are the primary identified risk for childhood cancers in SSA.
  • Burkitt Lymphoma, prevalent in tropical SSA, was the most reported cancer type. Risk factors were categorized as infection-induced, genetic, and demographic.
  • Overall, evidence on pediatric cancer risk factors in SSA remains limited.

Conclusions:

  • Scarcity of evidence on pediatric cancer risk factors and burden in SSA impedes effective childhood cancer control strategies.
  • Developing targeted preventative measures and treatment protocols requires a comprehensive understanding of identified risk factors.
  • Further research is crucial to address the knowledge gaps in pediatric oncology within the SSA region.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
472
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Criteria for Causality: Bradford Hill Criteria - II01:28

Criteria for Causality: Bradford Hill Criteria - II

The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
724
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
186
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.5K
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
278